A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study. [electronic resource]
- Annals of the rheumatic diseases Oct 2013
- 1613-20 p. digital